{"title":"黑素瘤发病率和死亡率的全球流行病学趋势。","authors":"Nicola Cirillo","doi":"10.1093/skinhd/vzae013","DOIUrl":null,"url":null,"abstract":"<p><p>There is concern that increased surveillance is leading to the overdiagnosis of indolent melanomas that are not destined to be lethal. As overdiagnosis can only be appreciated at a population level, we analysed current and historical population trends of melanoma incidence and mortality worldwide. Epidemiological trends from GLOBOCAN data show signatures typical of overdiagnosis, with the magnitude of increased diagnoses far outpacing mortality for melanoma in most countries.</p>","PeriodicalId":74804,"journal":{"name":"Skin health and disease","volume":"5 1","pages":"84-86"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11924397/pdf/","citationCount":"0","resultStr":"{\"title\":\"Global epidemiological trends in the incidence and mortality for melanoma.\",\"authors\":\"Nicola Cirillo\",\"doi\":\"10.1093/skinhd/vzae013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>There is concern that increased surveillance is leading to the overdiagnosis of indolent melanomas that are not destined to be lethal. As overdiagnosis can only be appreciated at a population level, we analysed current and historical population trends of melanoma incidence and mortality worldwide. Epidemiological trends from GLOBOCAN data show signatures typical of overdiagnosis, with the magnitude of increased diagnoses far outpacing mortality for melanoma in most countries.</p>\",\"PeriodicalId\":74804,\"journal\":{\"name\":\"Skin health and disease\",\"volume\":\"5 1\",\"pages\":\"84-86\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-01-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11924397/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Skin health and disease\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/skinhd/vzae013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/2/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Skin health and disease","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/skinhd/vzae013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/2/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
Global epidemiological trends in the incidence and mortality for melanoma.
There is concern that increased surveillance is leading to the overdiagnosis of indolent melanomas that are not destined to be lethal. As overdiagnosis can only be appreciated at a population level, we analysed current and historical population trends of melanoma incidence and mortality worldwide. Epidemiological trends from GLOBOCAN data show signatures typical of overdiagnosis, with the magnitude of increased diagnoses far outpacing mortality for melanoma in most countries.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
